| Finding | Percentage | Cases |
|---|---|---|
| Gender | ||
| Male | 63.6% | 7/11 |
| Female | 36.4% | 4/11 |
| Indifferent | 0% | 0/11 |
| Unknown | 0% | 0/11 |
| General | ||
| 9.1% | 1/11 | |
| 9.1% | 1/11 | |
| 9.1% | 1/11 | |
| 9.1% | 1/11 | |
| 36.4% | 4/11 | |
| 18.2% | 2/11 | |
| 100% | 11/11 | |
| 100% | 11/11 | |
| 72.7% | 8/11 | |
| 42.9% | 3/7 | |
| Neurology | ||
| 81.8% | 9/11 | |
| 45.5% | 5/11 | |
| 36.4% | 4/11 | |
| Facial abnormalities | ||
| 72.7% | 8/11 | |
| 100% | 11/11 | |
| 90.9% | 10/11 | |
| 100% | 11/11 | |
| Visual and hearing impairments | ||
| 9.1% | 1/11 | |
| 18.2% | 2/11 | |
| Heart | ||
| 27.3% | 3/11 | |
| Pulmonary | ||
| 27.3% | 3/11 | |
| Gastrointestinal | ||
| 36.4% | 4/11 | |
| Urogenital | ||
| 18.2% | 2/11 | |
| Skeleton | ||
| 100% | 11/11 | |
| Skin / Hair / Nails | ||
| 63.6% | 7/11 | |
| Endocrine / Immunological / Metabolic | ||
| Endocrine | 0% | 0/11 |
| 9.1% | 1/11 | |
| 27.3% | 3/11 | |
| Neoplasia | ||
| Neoplasia | 0% | 0/11 |
| Inheritance | ||
| 90.9% | 10/11 | |
CNOT2